These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18423312)

  • 21. Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis.
    Walker-Samuel S; Leach MO; Collins DJ
    Phys Med Biol; 2006 Jul; 51(14):3593-602. PubMed ID: 16825751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
    Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time.
    Medved M; Karczmar G; Yang C; Dignam J; Gajewski TF; Kindler H; Vokes E; MacEneany P; Mitchell MT; Stadler WM
    J Magn Reson Imaging; 2004 Jul; 20(1):122-8. PubMed ID: 15221817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.
    Graff BA; Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
    J Magn Reson Imaging; 2005 Mar; 21(3):272-81. PubMed ID: 15723369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
    Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the prostate.
    Bonekamp D; Macura KJ
    Top Magn Reson Imaging; 2008 Dec; 19(6):273-84. PubMed ID: 19512849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DCE-MRI pixel-by-pixel quantitative curve pattern analysis and its application to osteosarcoma.
    Guo JY; Reddick WE
    J Magn Reson Imaging; 2009 Jul; 30(1):177-84. PubMed ID: 19557806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic MRI in indirect estimation of microvessel density, histologic grade, and prognosis in colorectal adenocarcinomas.
    Tuncbilek N; Karakas HM; Altaner S
    Abdom Imaging; 2004; 29(2):166-72. PubMed ID: 15290941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study.
    Liu G; Rugo HS; Wilding G; McShane TM; Evelhoch JL; Ng C; Jackson E; Kelcz F; Yeh BM; Lee FT; Charnsangavej C; Park JW; Ashton EA; Steinfeldt HM; Pithavala YK; Reich SD; Herbst RS
    J Clin Oncol; 2005 Aug; 23(24):5464-73. PubMed ID: 16027440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: feasibility study and preliminary results using a distributed-parameter tracer kinetic analysis.
    Bisdas S; Baghi M; Wagenblast J; Vogl TJ; Thng CH; Koh TS
    J Magn Reson Imaging; 2008 May; 27(5):963-9. PubMed ID: 18407543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
    Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
    Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure.
    Gulliksrud K; Brurberg KG; Rofstad EK
    Radiother Oncol; 2009 Apr; 91(1):107-13. PubMed ID: 18973959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses.
    Ng CS; Raunig DL; Jackson EF; Ashton EA; Kelcz F; Kim KB; Kurzrock R; McShane TM
    AJR Am J Roentgenol; 2010 Feb; 194(2):W134-40. PubMed ID: 20093564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
    Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
    Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis.
    Atkin G; Taylor NJ; Daley FM; Stirling JJ; Richman P; Glynne-Jones R; d'Arcy JA; Collins DJ; Padhani AR
    Br J Surg; 2006 Aug; 93(8):992-1000. PubMed ID: 16673354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A method for pharmacokinetic modelling of dynamic contrast enhanced MRI studies of rapidly enhancing lesions acquired in a clinical setting.
    Radjenovic A; Ridgway JP; Smith MA
    Phys Med Biol; 2006 May; 51(9):N187-97. PubMed ID: 16625029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic contrast-enhanced (DCE) derived transfer coefficient (ktrans) is a surrogate marker of matrix metalloproteinase 9 (MMP-9) expression in brain tuberculomas.
    Haris M; Husain N; Singh A; Awasthi R; Singh Rathore RK; Husain M; Gupta RK
    J Magn Reson Imaging; 2008 Sep; 28(3):588-97. PubMed ID: 18777539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
    Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
    Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.